Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
International Psychogeriatrics|May 21, 2015
Decreased hemoglobin levels, cerebral small-vessel disease, and cortical atrophy: among cognitively normal elderly women and menSang Eon Park, Hojeong Kim, Jeongmin Lee, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 6, 2025
Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profilesDaeun Shin, Hyemin Jang, Heejin Yoo, et al.
Neurology|January 15, 2016
Early- vs late-onset subcortical vascular cognitive impairmentYoung Kyoung Jang, Hunki Kwon, Yeo Jin Kim, et al.
Journal of Clinical Medicine|April 23, 2022
Survival in Korean Patients with Frontotemporal Dementia Syndrome: Association with Behavioral Features and ParkinsonismNa-Yeon Jung, Kee Hyung Park, Sang Won Seo, et al.
Journal of Alzheimer'S Disease : JAD|February 11, 2020
Comparison of Diagnostic Performances Between Cerebrospinal Fluid Biomarkers and Amyloid PET in a Clinical SettingNa-Yeon Jung, Eun Soo Kim, Hyang-Sook Kim, et al.
Alzheimer Disease and Associated Disorders|June 11, 2020
Comparison of Amyloid in Cerebrospinal Fluid, Brain Imaging, and Autopsy in a Case of Progressive Supranuclear PalsyKyung Hye Kim, Jae Deuk Seo, Eun Soo Kim, et al.
Journal of Alzheimer'S Disease Reports|November 30, 2022
Genetic Screening in Korean Patients with Frontotemporal Dementia SyndromeEun-Joo Kim, Duk L Na, Hee-Jin Kim, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2025
Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnosticsHyemin Jang, Daeun Shin, Heejin Yoo, et al.
Clinical Nuclear Medicine|September 5, 2025
Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer DiseaseSohyun Yim, Yuna Gu, Heekyung Kang, et al.
Pageof 7